This is why the Wegovy vs Zepbound debate isnt really about which one is universally better, its about which one your body responds to
Well go on to discuss how to do this
Those are the types of clues Eli Lillys CEO, David Ricks, says his company will pursue next year, testing whether its GLP-1 drug, tirzepatide (called Mounjaro for diabetes treatment, and Zepbound for weight loss), could help with addiction to alcohol, nicotine, and other things we dont think about [as being] connected to weight. In comments he made in December, Ricks said the drugs might be anti-hedonicsmeaning they counteract our hedonistic pursuit of pleasure, be it from food, alcohol, or drugs
That means anyone using it, or Novo Nordisk's Wegovy, for weight loss are likely paying out of pocket
Peptyd dziaa gwnie poprzez modulacj szlaku czynnika wzrostu rdbonka naczyniowego (VEGF) i ukadu NO